Iron Fortified Beverages and Application in Women Predisposed to Anemia (FeDrink)
Primary Purpose
Iron-deficiency Anemia
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
non-fortified fruit juices consumed as part of the usual diet
Iron fortified fruit juice
Sponsored by
About this trial
This is an interventional prevention trial for Iron-deficiency Anemia focused on measuring Ferric pyrophosphate, Fortification, Fruit juice, Functional food, Bioavailability, iron status, Women, iron-deficiency anemia
Eligibility Criteria
Inclusion Criteria:
- Women
- non-smoker
- non-pregnant
- non-breastfeeding
- serum ferritin <40 ng/ml
- hemoglobin>=11g/dl
Exclusion Criteria:
- Serum Ferritin >=40 ng/ml
- Hemoglobin <11g/dl
- Amenorrhea
- Menopause
- Iron deficiency anemia
- Thalassemia
- Hemochromatosis
- Blood donors
- Chronic gastric diseases
- Renal diseases
- Eating disorders
- Allergy to any component of the study juices
- Consumption of iron or ascorbic acid supplements within 4 month prior to participating in the study
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Experimental
Arm Label
Placebo juices
Iron fortified fruit juices
Arm Description
Consumption of non-iron fortified fruit juices as part of the usual diet
Consumption of iron fortified fruit juices as part of the usual diet
Outcomes
Primary Outcome Measures
Serum Ferritin
Secondary Outcome Measures
Serum transferrin
Hemoglobin
serum iron
transferrin saturation
soluble transferrin receptor
zinc protoporphyrin
Total red blood cells
Hematocrit
Mean corpuscular volume
Red blood cell distribution width
25-hydroxycholecalciferol
alkaline phosphatase bone-isoenzyme (ALP)
serum cross-linked N-telopeptide of type I collagen (NTx)
Total cholesterol
HDL-cholesterol
LDL-cholesterol
Glucose
Serum triacylglycerols
T-chol/HDL-chol
LDL-chol/HDL-chol
Systolic blood pressure
Diastolic blood pressure
Full Information
NCT ID
NCT01135576
First Posted
May 28, 2010
Last Updated
December 21, 2012
Sponsor
National Research Council, Spain
Collaborators
Ministry of Science and Innovation, Spain, Grupo Leche Pascual, Madrid Salud, Madrid, Spain
1. Study Identification
Unique Protocol Identification Number
NCT01135576
Brief Title
Iron Fortified Beverages and Application in Women Predisposed to Anemia
Acronym
FeDrink
Study Type
Interventional
2. Study Status
Record Verification Date
December 2012
Overall Recruitment Status
Completed
Study Start Date
November 2008 (undefined)
Primary Completion Date
January 2009 (Actual)
Study Completion Date
May 2009 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National Research Council, Spain
Collaborators
Ministry of Science and Innovation, Spain, Grupo Leche Pascual, Madrid Salud, Madrid, Spain
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of the study is to know if consumption of an iron fortified fruit juice containing micronized iron pyrophosphate, is useful to increase iron status in women predisposed to iron deficiency anemia.
A secondary objective is to know if consumption of this iron fortified fruit juice modifies bone remodelling.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Iron-deficiency Anemia
Keywords
Ferric pyrophosphate, Fortification, Fruit juice, Functional food, Bioavailability, iron status, Women, iron-deficiency anemia
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
122 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Placebo juices
Arm Type
Placebo Comparator
Arm Description
Consumption of non-iron fortified fruit juices as part of the usual diet
Arm Title
Iron fortified fruit juices
Arm Type
Experimental
Arm Description
Consumption of iron fortified fruit juices as part of the usual diet
Intervention Type
Dietary Supplement
Intervention Name(s)
non-fortified fruit juices consumed as part of the usual diet
Intervention Type
Dietary Supplement
Intervention Name(s)
Iron fortified fruit juice
Intervention Description
Consumption of micronized iron pyrophosphate supplemented fruit juices as part of the usual diet
Primary Outcome Measure Information:
Title
Serum Ferritin
Time Frame
monitored during 16 weeks
Secondary Outcome Measure Information:
Title
Serum transferrin
Time Frame
monitored during 16 weeks
Title
Hemoglobin
Time Frame
monitored during 16 weeks
Title
serum iron
Time Frame
monitored during 16 weeks
Title
transferrin saturation
Time Frame
monitored during 16 weeks
Title
soluble transferrin receptor
Time Frame
monitored during 16 weeks
Title
zinc protoporphyrin
Time Frame
monitored during 16 weeks
Title
Total red blood cells
Time Frame
monitored during 16 weeks
Title
Hematocrit
Time Frame
monitored during 16 weeks
Title
Mean corpuscular volume
Time Frame
monitored during 16 weeks
Title
Red blood cell distribution width
Time Frame
monitored during 16 weeks
Title
25-hydroxycholecalciferol
Time Frame
monitored during 16 weeks
Title
alkaline phosphatase bone-isoenzyme (ALP)
Time Frame
monitored during 16 weeks
Title
serum cross-linked N-telopeptide of type I collagen (NTx)
Time Frame
monitored during 16 weeks
Title
Total cholesterol
Time Frame
monitored during 16 weeks
Title
HDL-cholesterol
Time Frame
monitored during 16 weeks
Title
LDL-cholesterol
Time Frame
monitored during 16 weeks
Title
Glucose
Time Frame
monitored during 16 weeks
Title
Serum triacylglycerols
Time Frame
monitored during 16 weeks
Title
T-chol/HDL-chol
Time Frame
monitored during 16 weeks
Title
LDL-chol/HDL-chol
Time Frame
monitored during 16 weeks
Title
Systolic blood pressure
Time Frame
monitored during 16 weeks
Title
Diastolic blood pressure
Time Frame
monitored during 16 weeks
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Women
non-smoker
non-pregnant
non-breastfeeding
serum ferritin <40 ng/ml
hemoglobin>=11g/dl
Exclusion Criteria:
Serum Ferritin >=40 ng/ml
Hemoglobin <11g/dl
Amenorrhea
Menopause
Iron deficiency anemia
Thalassemia
Hemochromatosis
Blood donors
Chronic gastric diseases
Renal diseases
Eating disorders
Allergy to any component of the study juices
Consumption of iron or ascorbic acid supplements within 4 month prior to participating in the study
12. IPD Sharing Statement
Citations:
PubMed Identifier
19886395
Citation
Navas-Carretero S, Perez-Granados AM, Schoppen S, Sarria B, Carbajal A, Vaquero MP. Iron status biomarkers in iron deficient women consuming oily fish versus red meat diet. J Physiol Biochem. 2009 Jun;65(2):165-74. doi: 10.1007/BF03179067.
Results Reference
background
PubMed Identifier
19210857
Citation
Navas-Carretero S, Perez-Granados AM, Schoppen S, Vaquero MP. An oily fish diet increases insulin sensitivity compared to a red meat diet in young iron-deficient women. Br J Nutr. 2009 Aug;102(4):546-53. doi: 10.1017/S0007114509220794. Epub 2009 Feb 12.
Results Reference
background
PubMed Identifier
18752926
Citation
Navas-Carretero S, Perez-Granados AM, Sarria B, Vaquero MP. Iron absorption from meat pate fortified with ferric pyrophosphate in iron-deficient women. Nutrition. 2009 Jan;25(1):20-4. doi: 10.1016/j.nut.2008.07.002. Epub 2008 Aug 26.
Results Reference
background
PubMed Identifier
18460487
Citation
Navas-Carretero S, Perez-Granados AM, Sarria B, Carbajal A, Pedrosa MM, Roe MA, Fairweather-Tait SJ, Vaquero MP. Oily fish increases iron bioavailability of a phytate rich meal in young iron deficient women. J Am Coll Nutr. 2008 Feb;27(1):96-101. doi: 10.1080/07315724.2008.10719680.
Results Reference
background
PubMed Identifier
17587790
Citation
Navas-Carretero S, Sarria B, Perez-Granados AM, Schoppen S, Izquierdo-Pulido M, Vaquero MP. A comparative study of iron bioavailability from cocoa supplemented with ferric pyrophosphate or ferrous fumarate in rats. Ann Nutr Metab. 2007;51(3):204-7. doi: 10.1159/000104138. Epub 2007 Jun 18.
Results Reference
background
PubMed Identifier
17206377
Citation
Sarria B, Navas-Carretero S, Lopez-Parra AM, Perez-Granados AM, Arroyo-Pardo E, Roe MA, Teucher B, Vaquero MP, Fairweather-Tait SJ. The G277S transferrin mutation does not affect iron absorption in iron deficient women. Eur J Nutr. 2007 Feb;46(1):57-60. doi: 10.1007/s00394-006-0631-x. Epub 2007 Jan 5.
Results Reference
background
Citation
Navas-Carretero S, Pérez-Granados AM, Sarriá B, Schoppen S, Vaquero MP. Iron bioavailability from pate enriched with encapsulated ferric pyrophosphate or ferrous gluconate in rats. Food Sci Tech Int 13:159-163, 2007.
Results Reference
background
PubMed Identifier
20593115
Citation
Toxqui L, De Piero A, Courtois V, Bastida S, Sanchez-Muniz FJ, Vaquero MP. [Iron deficiency and overload. Implications in oxidative stress and cardiovascular health]. Nutr Hosp. 2010 May-Jun;25(3):350-65. Spanish.
Results Reference
background
PubMed Identifier
22618893
Citation
Blanco-Rojo R, Perez-Granados AM, Toxqui L, Zazo P, de la Piedra C, Vaquero MP. Relationship between vitamin D deficiency, bone remodelling and iron status in iron-deficient young women consuming an iron-fortified food. Eur J Nutr. 2013 Mar;52(2):695-703. doi: 10.1007/s00394-012-0375-8. Epub 2012 May 23.
Results Reference
result
PubMed Identifier
21303569
Citation
Blanco-Rojo R, Perez-Granados AM, Toxqui L, Gonzalez-Vizcayno C, Delgado MA, Vaquero MP. Efficacy of a microencapsulated iron pyrophosphate-fortified fruit juice: a randomised, double-blind, placebo-controlled study in Spanish iron-deficient women. Br J Nutr. 2011 Jun;105(11):1652-9. doi: 10.1017/S0007114510005490. Epub 2011 Feb 8.
Results Reference
result
Learn more about this trial
Iron Fortified Beverages and Application in Women Predisposed to Anemia
We'll reach out to this number within 24 hrs